VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
QGEN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
QGENQiagen N.V.
$50.33$10.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksQGENCash Flow

Qiagen N.V. (QGEN) Cash Flow Statement

30Y historyFree accessUpdated daily

Qiagen exhibits exceptional cash conversion with an OCF/NI ratio of 1.94 in 2026Q2, supporting a robust FCF margin of 29.5% even as revenue growth stalls, though working capital swings have been volatile.

Income StatementBalance SheetCash FlowRatios

QGEN Cash Flow Statement

Annual statement

QGEN Cash Flow Statement

Qiagen N.V. (QGEN) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations654.47M654.33M673.55M459.45M715.26M639M492.27M330.84M359.5M286.78M341.6M317.5M287.96M258.96M244.88M244.78M250.75M217M173M84.81M101.48M91.24M53.8M64.06M36.69M58.09M38.87M26.18M11.6M8.5M4.1M
Operating CF Margin %-31.31%34.05%23.38%33.4%28.38%26.32%21.67%23.94%20.23%25.53%24.79%21.41%19.89%19.52%20.93%23.06%21.49%19.37%13.05%21.79%22.9%14.13%18.23%12.29%22.02%19.05%18.18%10.53%11.44%7.56%
Operating CF Growth %-14.94%-2.85%46.6%-35.76%11.93%29.81%48.79%-7.97%25.36%-16.05%7.59%10.26%11.2%5.75%0.04%-2.38%15.56%25.43%103.98%-16.43%11.23%69.59%-16.02%74.62%-36.84%49.43%48.5%125.66%36.47%107.32%5.13%
Net Income409.32M424.88M83.59M341.3M423.21M512.6M73.64M-41.45M190.38M40.39M80.3M126.86M117.2M69.1M129.54M94.95M144.31M137.77M89.03M50.12M70.54M62.23M48.7M42.85M23.14M34.42M20.11M12.62M12.4M8.8M5.3M
Depreciation & Amortization202.13M193.75M203.27M205.34M208.4M214.93M205.01M231.46M206.44M216.45M213.06M191.47M200.78M199.35M197.89M167.38M142.78M120.39M105.7M62.58M30.04M24.95M22.96M25.79M24.71M15.06M10.46M7.83M5.8M4.9M2.5M
Stock-Based Compensation36.95M50.4M43.63M47.1M49.51M38.39M40.94M65.89M40.11M34.44M28.29M27.57M42.19M37.94M25.36M19.54M13.59M9.75M9.79M8.98B326M0000000000
Deferred Taxes-26.56M-20.07M-23.04M10.73M-9.6M-5.29M-14.26M-55.36M-23.27M39.55M-65.97M-37.19M-41.29M-68.09M-22.77M-31.86M-19.94M-10.61M-17.69M-1.65M5.21M-2.2M-10.47M12.18M5.03M-1.79M-5.38M-1.53M-1M-900K400K
Other Non-Cash Items51.62M39.88M230.65M41.94M75.63M8.38M170.14M174.63M41M23.18M75.64M89.91M47.89M14.99M-1.27M37.69M-14.09M-5.51M4.24M-8.95B-325.23M10.01M12.62M8.38M-1.88M16.25M25.66M6.24M100K400K100K
Working Capital Changes-18.98M-34.51M135.45M-186.96M-31.88M-130.01M16.8M-44.32M-95.16M-67.23M10.29M-81.11M-78.81M5.67M-83.87M-42.92M-15.9M-34.8M-18.07M-55.83M-5.08M-3.75M-20.01M-25.14M-14.31M-5.85M-11.97M1.02M-6.3M-4.7M-4.2M
Change in Receivables-7.31M-36.39M12.22M-55.12M15.45M-7.4M-14.71M-39.58M-41.81M-34.16M-12.24M-24.76M-16.56M-14.92M-14.29M-28.2M-6.88M-25.21M-19.08M1.81B378M54M128M1.75B631M000000
Change in Inventory-30.04M-848K87.75M-44.79M-61.95M-81.8M-107.57M-30.03M-36.92M-21.63M-20.35M-33.19M-41.79M-17.5M-20.38M-15.95M2.35M-21.53M-30.37M-8.74M-4.2M3.76M2.02M-6.4M-18.18M-3.93M-6.59M-3.7M-3.2M-6M-4.2M
Change in Payables-1.56M-8.42M1.45M-22.42M-1.76M-5.97M8.44M9.25M6.99M4.32M-1.47M7.73M-5.5M-6.79M-9.95M7.26M3.48M-9.08M5.75M956M2.72B-4.71B599M-6.61B-424M000000
Cash from Investing-242.15M-305.28M-249.23M-87.66M-726.76M-202.43M-453.29M-222.28M-211.36M-464.26M-179.06M-146.2M-407.6M-251.74M-300.89M-540.32M-215.51M-341.74M-210.52M-659.67M-165.47M-98.5M-51.15M-14.06M-64.79M-90.8M-45.03M-23.73M-11.7M-5.9M-38.3M
Capital Expenditures-213.87M-207.13M-167.17M-162.8M-149.34M-206.53M-304.24M-274.88M-150.76M-124.41M-93.92M-117.48M-97M-118.69M-128.09M-121.39M-123.91M-69.36M-57.92M-58.61M-35.35M-13.73M-12.62M-19.56M-59.14M-102.07M-39.45M-11.81M-10.5M-6.8M-9.7M
CapEx % of Revenue10.18%9.91%8.45%8.28%6.97%9.17%16.27%18.01%10.04%8.78%7.02%9.17%7.21%9.12%10.21%10.38%11.39%6.87%6.49%9.02%7.59%3.45%3.32%5.57%19.8%38.7%19.33%8.2%9.53%9.15%17.9%
Acquisitions-226.5M-291.23M0-149.53M-63.65M-16.63M-239.57M-67.06M-172.83M-50.55M-90.49M-66.93M-160.44M-170.55M-132M-457.48M-36.98M-234.73M-150.53M-859.69M-95.38M-82M17.67M1.79M-14.06M274K385K98K000
Investments-------------------------------
Other Investing-30.91M-32.16M21.35M-66.55M-9.77M61.47M-66.57M22.7M-2.13M-22.98M-8.74M-5.88M3.64M-977K1.31M2.02M3.47M869K-208K5.82M1.91M-17.76M-33.1M-2.78M-2.37M-2.32M-817K-32K-2.6M-1M-500K
Cash from Financing-376.41M-178.98M-422.9M-433.83M-125.8M-150.37M-74.32M-639.08M360.41M387.19M-10.6M-258.61M192.84M-68.76M226.6M-310.63M-35.23M629.2M12.77M494.05M303.16M2.96M95.62M-1.88M6.12M66.25M14.84M3.6M1.8M3.2M31.9M
Debt Issued (Net)208.15M208.15M-107.33M-436.76M-108.55M-41.34M-35.55M-505.43M493.57M722.86M-8.06M-252.95M325.34M-6.49M249.22M-429.56M-50.25M-27.99M-5M440.23M284.45M-5.46M90.49M-4M3.79M58.56M-5.92M1.72M714K2.5M800K
Equity Issued (Net)-508.79M-307.36M-292.1M-17.68M-25.36M-92.07M-77.84M-72.38M-104.69M-304.92M6.27M-10.5M-126.89M-60.69M-35.65M011.24M650.49M18.45M42.28M11.01M7.96M5.13M2.11M2.33M4.09M20.76M2.68M939K700K31.1M
Dividends Paid-54.24M-54.24M00000000000000000000000000000
Share Repurchases-508.79M-307.36M-292.1M-17.68M-25.36M-99.99M-63.99M-74.45M-104.69M-60.97M0-20.82M-126.89M-86.03M-35.65M0000000000000000
Other Financing-21.52M-25.53M-23.47M20.61M8.11M-16.95M39.07M-61.28M-28.48M-30.76M-8.81M4.84M-5.61M-129K13.04M-2.39M3.78M6.7M-686K11.54M7.7M455K0003.6M0-803K147K00
Net Change in Cash34.69M175.45M-4.53M-62.59M-149.85M282.53M-31.23M-529.69M501.37M218.53M149.17M-102.66M62.36M-63.73M172.9M-607.27M2.85M492.24M-14.01M-83.04M238.66M-4.67M97.38M54.1M-11.57M32.45M9.14M5.8M2M2.3M-3.3M
Free Cash Flow447.7M453.28M506.38M296.65M565.93M432.47M188.03M55.96M208.73M162.37M247.68M200.02M190.96M140.26M116.8M123.39M126.84M147.64M115.08M26.2M66.13M77.51M41.18M44.5M-22.45M-43.98M-573K14.37M1.1M1.7M-5.6M
FCF Margin %21.32%21.69%25.6%15.09%26.43%19.21%10.05%3.67%13.9%11.45%18.51%15.61%14.2%10.77%9.31%10.55%11.66%14.62%12.89%4.03%14.2%19.46%10.82%12.66%-7.52%-16.67%-0.28%9.98%1%2.29%-10.33%
FCF Growth %-9.8%-10.49%70.7%-47.58%30.86%129.99%236.02%-73.19%28.55%-34.44%23.83%4.74%36.14%20.09%-5.35%-2.72%-14.09%28.29%339.29%-60.38%-14.69%88.23%-7.47%298.23%48.95%-7575.39%-103.99%1205.91%-35.29%130.36%-354.55%
FCF per Share2.152.182.321.362.541.920.830.250.890.701.080.880.820.600.500.540.550.720.590.150.450.540.290.31-0.16-0.31-0.000.110.010.01-0.05
FCF Conversion (FCF/Net Income)1.09x1.54x8.06x1.35x1.69x1.25x1.37x-7.98x1.89x7.10x4.25x2.44x2.47x3.75x1.89x2.55x1.74x1.58x1.94x1.69x1.44x1.47x1.10x1.49x1.59x1.69x1.85x1.88x0.88x0.97x0.77x
Interest Paid0024.18M20.35M23.21M21.59M25.35M29.72M25.9M20.25M18.23M20.8M24.05M31M17.3M20.76M25.56M27.66M36.46M000000000000
Taxes Paid0015.68M82.41M120.48M102.08M42.57M41.47M29.32M40.5M22.67M34.44M12.54M14.52M61.59M41.49M33.78M36M39.48M000000000000

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetAdequate
Cash FlowRobust
Top Statement Risk

Acquisition integration risk

Exceptional Cash Conversion Quality

Qiagen consistently converts net income into operating cash flow at a rate far exceeding 100%, with the OCF/NI ratio averaging 1.56 over the last ten quarters, indicating high-quality, cash-rich earnings.

Based on reported financial statements, the company's operating cash flow has exceeded net income in nine of the last ten quarters, with the sole exception being a quarter with a large non-cash impairment charge. This persistent gap is primarily driven by substantial non-cash depreciation and amortization charges of approximately $50M per quarter, which are added back to net income to calculate operating cash flow. The pattern suggests the core business is generating significantly more cash than accounting profits indicate, a hallmark of a mature, capital-efficient operation.

FCF Margin Resilience Despite Growth Slowdown

Despite revenue growth decelerating to 0.3% in 2026Q2, free cash flow margin has remained robust at 29.5%, demonstrating the company's ability to maintain strong cash generation even in a challenging top-line environment.

According to Qiagen's cash flow statements, FCF margins have consistently ranged between 20-30% over the past ten quarters, a level that is exceptionally strong for the industrial sector. This resilience is driven by the high cash conversion noted earlier and disciplined capital expenditure, which has averaged about 9% of revenue. The current high FCF margin, achieved despite stagnant revenue, implies that profitability and working capital efficiency are currently the primary drivers of cash generation, not growth.

Aggressive Shareholder Returns via Buybacks

Qiagen has deployed substantial capital toward share repurchases, committing over $1.1 billion in the last six quarters alone, which appears to be its primary capital allocation priority over dividends or significant acquisitions.

As reported in recent SEC filings, the company's buyback activity has been concentrated, with large single-quarter outlays of $496.7M in 2026Q1 and $280.1M in 2025Q1. This pattern suggests management views its stock as an attractive investment at prevailing valuations. However, the lack of consistent dividend payments and only sporadic, modest acquisition spending (e.g., $224.6M in 2025Q4) indicates a capital allocation strategy heavily skewed towards returning cash to shareholders via buybacks rather than reinvesting for organic growth or strategic expansion.

Volatile Working Capital Swings

Working capital changes have been highly volatile, swinging from a $105.7M source of cash in 2024Q2 to a $42.1M use in 2026Q1, indicating inconsistent cash management efficiency that obscures underlying cash flow trends.

Based on the provided data, the large positive working capital contribution in 2024Q2 coincided with a reported net loss, suggesting a significant receivables collection or inventory reduction that masked operational weakness. Conversely, the large negative swings in early 2025 and 2026Q1 imply cash was tied up in inventory or receivables. This volatility makes it difficult to assess the true operational cash flow trajectory on a quarter-to-quarter basis and warrants monitoring for any sustained deterioration in cash conversion efficiency.

Cash Flow Strength Masks Strategic Limits

While the cash flow profile is robust, it may conceal a strategic dilemma: the company is generating far more cash than its slowing growth and limited acquisition activity can deploy, leading to a heavy reliance on buybacks that may not be the optimal use of capital.

The analysis suggests Qiagen's impressive FCF generation is occurring against a backdrop of near-zero revenue growth, which was highlighted in the prior income statement review. The aggressive buybacks could be interpreted as a signal that management lacks high-return reinvestment opportunities within its core diagnostic and research markets. Furthermore, the absence of significant dividend payments limits shareholder return flexibility. Investors should monitor whether this cash-rich profile is a temporary phase or indicative of a structural shift towards a mature, low-growth business model.

QGEN — Frequently Asked Questions

Quick answers to the most common questions about buying QGEN stock.

How much cash does Qiagen N.V. (QGEN) generate from operations?

Qiagen N.V. (QGEN) generated $654.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Qiagen N.V.'s free cash flow?

Qiagen N.V. (QGEN) generated $453.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Qiagen N.V.'s capital expenditure (CapEx)?

Qiagen N.V. (QGEN) spent $207.1M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Qiagen N.V. distribute cash to shareholders?

In 2025, Qiagen N.V. (QGEN) returned $54.2M to shareholders via cash dividends and spent $307.4M on share repurchases. This shows the company's commitment to returning capital to its equity investors.